These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2777064)

  • 41. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall.
    Gobin J; Horwitz MA
    J Exp Med; 1996 Apr; 183(4):1527-32. PubMed ID: 8666910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mycobactins as chemotaxonomic characters for some rapidly growing mycobacteria.
    Hall RM; Ratledge C
    J Gen Microbiol; 1984 Aug; 130(8):1883-92. PubMed ID: 6470673
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel antimycobacterial compound acts as an intracellular iron chelator.
    Dragset MS; Poce G; Alfonso S; Padilla-Benavides T; Ioerger TR; Kaneko T; Sacchettini JC; Biava M; Parish T; Argüello JM; Steigedal M; Rubin EJ
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2256-64. PubMed ID: 25645825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of metal ions on the formation of mycobactin and salicylic acid in Mycobacterium smegmatis grown in static culture.
    Ratledge C; Hall MJ
    J Bacteriol; 1971 Oct; 108(1):314-9. PubMed ID: 4941561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Iron Homeostasis in Mycobacterium tuberculosis: Mechanistic Insights into Siderophore-Mediated Iron Uptake.
    Sritharan M
    J Bacteriol; 2016 Sep; 198(18):2399-409. PubMed ID: 27402628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transport of iron by mycobactin in Mycobacterium smegmatis.
    Ratledge C
    Biochem Biophys Res Commun; 1971 Nov; 45(4):856-62. PubMed ID: 5117557
    [No Abstract]   [Full Text] [Related]  

  • 47. Isolation, purification and structure of exochelin MS, the extracellular siderophore from Mycobacterium smegmatis.
    Sharman GJ; Williams DH; Ewing DF; Ratledge C
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):187-96. PubMed ID: 7826328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of mycobactin in Mycobacterium leprae; probably a microbe dependent microorganism implications.
    Kato L
    Indian J Lepr; 1985; 57(1):58-70. PubMed ID: 3897405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iron chelation properties of an extracellular siderophore exochelin MS.
    Dhungana S; Ratledge C; Crumbliss AL
    Inorg Chem; 2004 Oct; 43(20):6274-83. PubMed ID: 15446873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iron transport in Mycobacterium smegmatis: the role of mycobactin.
    Ratledge C; Marshall BJ
    Biochim Biophys Acta; 1972 Aug; 279(1):58-74. PubMed ID: 4652567
    [No Abstract]   [Full Text] [Related]  

  • 51. Total synthesis of exochelin MN and analogues.
    Dong L; Miller MJ
    J Org Chem; 2002 Jul; 67(14):4759-70. PubMed ID: 12098286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iron transport in mycobacterium smegmatis: uptake of iron from Ferriexochelin.
    Stephenson MC; Ratledge C
    J Gen Microbiol; 1979 Jan; 110(1):193-202. PubMed ID: 430028
    [No Abstract]   [Full Text] [Related]  

  • 53. Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells.
    Pahl PM; Horwitz MA; Horwitz KB; Horwitz LD
    Breast Cancer Res Treat; 2001 Sep; 69(1):69-79. PubMed ID: 11759830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. THE STRUCTURE OF MYCOBACTIN P, A GROWTH FACTOR FOR MYCOBACTERIUM JOHNEI, AND THE SIGNIFICANCE OF ITS IRON COMPLEX.
    SNOW GA
    Biochem J; 1965 Jan; 94(1):160-5. PubMed ID: 14342223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Employment of tuberculostasis in serum-agar medium for the study of production and activity of Mycobactin.
    Kochan I; Cahall DL; Golden CA
    Infect Immun; 1971 Aug; 4(2):130-7. PubMed ID: 5005292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iron acquisition strategies in mycobacteria.
    Fang Z; Sampson SL; Warren RM; Gey van Pittius NC; Newton-Foot M
    Tuberculosis (Edinb); 2015 Mar; 95(2):123-30. PubMed ID: 25636179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mycobactins and exochelins of Mycobacterium tuberculosis, M. bovis, M. africanum and other related species.
    Barclay R; Ratledge C
    J Gen Microbiol; 1988 Mar; 134(3):771-6. PubMed ID: 3141575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Separable roles for Mycobacterium tuberculosis ESX-3 effectors in iron acquisition and virulence.
    Tufariello JM; Chapman JR; Kerantzas CA; Wong KW; Vilchèze C; Jones CM; Cole LE; Tinaztepe E; Thompson V; Fenyö D; Niederweis M; Ueberheide B; Philips JA; Jacobs WR
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E348-57. PubMed ID: 26729876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we stand.
    Shyam M; Shilkar D; Rakshit G; Jayaprakash V
    Expert Opin Drug Discov; 2022 Jul; 17(7):699-715. PubMed ID: 35575503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iron, mycobacteria and tuberculosis.
    Ratledge C
    Tuberculosis (Edinb); 2004; 84(1-2):110-30. PubMed ID: 14670352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.